BTG (BTG PLC) is a global healthcare company headquartered in London. Their medicine focused portfolio is aimed at treating cancer, emphysema, blood clots and other rare diseases. BTG licensed products are Lemtrada, Zytiga and others. A list of specialty pharmaceuticals includes CroFab, Vistogard, DigiFab and more. BTG share price information: BTG shares are traded on the London Stock Exchange (LSE). The company is a member of the FTSE 250 index. To receive real-time quotes for BTG stock, follow Capital.com.